GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $800,770 | -30.2% | 22,704 | -24.8% | 0.14% | -29.1% |
| Q2 2023 | $1,148,054 | +454.6% | 30,204 | +537.8% | 0.20% | +434.2% |
| Q3 2021 | $207,000 | -1.9% | 4,736 | -8.2% | 0.04% | 0.0% |
| Q2 2021 | $211,000 | -84.4% | 5,160 | -87.1% | 0.04% | -90.3% |
| Q2 2020 | $1,352,000 | +553.1% | 39,900 | +309.2% | 0.39% | +431.1% |
| Q1 2020 | $207,000 | -17.5% | 9,750 | -13.3% | 0.07% | -5.1% |
| Q4 2019 | $251,000 | +5.5% | 11,250 | -4.3% | 0.08% | -2.5% |
| Q3 2019 | $238,000 | – | 11,750 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |